Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
Abstract Background The aberrant expression of N-glycolyl GM3 ganglioside (NeuGcGM3) in patients with sarcomas was reevaluated by assessing the relation of this molecule with some clinicopathological features and overall survival (OS) of patients. Methods Fifty formalin-fixed and paraffin-embedded s...
Main Authors: | Daniel Pilco-Janeta, Myriam De la Cruz Puebla, Jorge Soriano, Marta Osorio, Iraida Caballero, Adanays Calvo Pérez, Laynes Savon, Natalia Cremades, Rancés Blanco, Adriana Carr |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5743-9 |
Similar Items
-
N-glycolyl chondroitin synthesis using metabolically engineered E. coli
by: Adeola E. Awofiranye, et al.
Published: (2020-08-01) -
Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
by: Charles Finsterwald, et al.
Published: (2021-04-01) -
The Missing Link - Likely Pathogenetic Role of GM3 and Other Gangliosides in the Development of Diabetic Nephropathy
by: Igor Vukovic, et al.
Published: (2015-05-01) -
Isolation and Structure Elucidation of GM4-Type Gangliosides from the Okinawan Starfish Protoreaster nodosus
by: Tomofumi Miyamoto, et al.
Published: (2012-11-01) -
Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain
by: Paul D. Snyder, Jr., et al.
Published: (1972-01-01)